Could a short steroid course ease pain after knee surgery?
NCT ID NCT05097976
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a short course of the steroid methylprednisolone, taken as pills after knee replacement surgery, can reduce pain, opioid use, and nausea. About 420 adults having knee replacement for osteoarthritis will receive either the steroid or a placebo. The goal is to see if this simple addition to standard pain management improves recovery in the first week and beyond.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
methylprednisolone (a steroid anti-inflammatory drug)
What this could lead to
If it works, this could offer a simple way to improve recovery and reduce opioid use after knee replacement surgery.
What could go wrong
This is a phase 4 trial, but steroids have known risks like infection or blood sugar changes. The benefit may be small or not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOTAL KNEE ARTHROPLASTY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rush Oak Brook Outpatient Center
RECRUITINGOak Brook, Illinois, 60523, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact